Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-05-16 Sale |
2024-05-20 5:30 pm |
ATAI Life Sciences N.V. | ATAI | Brand Florian See Remarks |
151,303 | $1.92 | $290,502 | 331,030 (Indirect Direct) |
View |
| 2024-04-02 Sale |
2024-04-04 6:11 pm |
ATAI Life Sciences N.V. | ATAI | Johnson Anne Nagengast Chief Financial Officer |
27,410 | $1.85 | $50,709 | 73,590 (Direct) |
View |
| 2024-04-02 Sale |
2024-04-04 6:11 pm |
ATAI Life Sciences N.V. | ATAI | Rao Srinivas See Remarks |
61,640 | $1.85 | $114,034 | 116,860 (Indirect Direct) |
View |
| 2024-04-02 Sale |
2024-04-04 6:11 pm |
ATAI Life Sciences N.V. | ATAI | Kirpekar Sahil Chief Business Officer |
35,801 | $1.85 | $66,232 | 64,199 (Direct) |
View |
| 2023-11-16 Purchase |
2023-11-20 09:17 am |
ATAI Life Sciences N.V. | ATAI | Brand Florian See Remarks |
20,000 | $1.156 | $23,120 | 132,333 (Indirect Direct) |
View |
| 2023-09-13 Purchase |
2023-09-14 4:30 pm |
ATAI Life Sciences N.V. | ATAI | Brand Florian See Remarks |
40,000 | $1.4492 | $57,968 | 112,333 (Indirect Direct) |
View |
| 2023-03-29 Purchase |
2023-03-30 5:55 pm |
ATAI Life Sciences N.V. | ATAI | Brand Florian See Remarks |
70,000 | $1.4794 | $103,558 | 72,333 (Indirect Direct) |
View |
| 2023-03-29 Purchase |
2023-03-29 4:05 pm |
ATAI Life Sciences N.V. | ATAI | Apeiron Investment Group Ltd. Angermayer Christian 10% Owner |
1,214,297 | $1.318 | $1,600,443 | 33,885,999 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-13 Option Award |
2024-06-14 5:00 pm |
N/A 2034-06-13 |
ATAI Life Sciences N.V. | ATAI | JOHNSON SABRINA MARTUCCI Director |
103,000 | $0 | 103,000 (Direct) |
View |
| 2024-04-19 Other |
2024-05-03 4:05 pm |
2024-04-19 2026-02-01 |
IntelGenx Technologies Corp. | IGXT | ATAI Life Sciences N.V. ATAI Life Sciences AG 10% Owner |
1,000,000 | $0 | 10,500,000 (Indirect) |
View |
| 2024-04-15 Other |
2024-04-17 4:15 pm |
N/A N/A |
ATAI Life Sciences N.V. | ATAI | Apeiron Investment Group Ltd. Angermayer Christian 10% Owner |
295,900 | $0 | 147,950 (Indirect) |
View |
| 2024-03-13 Option Award |
2024-03-15 8:16 pm |
N/A 2034-03-13 |
ATAI Life Sciences N.V. | ATAI | Johnson Anne Nagengast Chief Financial Officer |
550,000 | $0 | 751,000 (Direct) |
View |
| 2024-03-14 Exercise |
2024-03-15 8:16 pm |
N/A N/A |
ATAI Life Sciences N.V. | ATAI | Johnson Anne Nagengast Chief Financial Officer |
100,000 | $0 | 751,000 (Direct) |
View |
| 2024-03-13 Option Award |
2024-03-15 8:16 pm |
N/A 2034-03-13 |
ATAI Life Sciences N.V. | ATAI | Kirpekar Sahil Chief Business Officer |
550,000 | $0 | 750,000 (Direct) |
View |
| 2024-03-14 Exercise |
2024-03-15 8:16 pm |
N/A N/A |
ATAI Life Sciences N.V. | ATAI | Kirpekar Sahil Chief Business Officer |
100,000 | $0 | 750,000 (Direct) |
View |
| 2024-03-13 Option Award |
2024-03-15 8:16 pm |
N/A 2034-03-13 |
ATAI Life Sciences N.V. | ATAI | Rao Srinivas See Remarks |
800,000 | $0 | 1,153,500 (Direct) |
View |
| 2024-03-14 Exercise |
2024-03-15 8:16 pm |
N/A N/A |
ATAI Life Sciences N.V. | ATAI | Rao Srinivas See Remarks |
175,000 | $0 | 1,153,500 (Direct) |
View |
| 2024-03-14 Exercise |
2024-03-15 8:16 pm |
N/A N/A |
ATAI Life Sciences N.V. | ATAI | Brand Florian See Remarks |
350,000 | $0 | 832,333 (Direct) |
View |
| 2023-09-30 Other |
2024-03-12 9:36 pm |
2023-09-30 2026-08-31 |
IntelGenx Technologies Corp. | IGXT | ATAI Life Sciences N.V. ATAI Life Sciences AG 10% Owner |
13,507,401 | $0 | 41,030,251 (Indirect) |
View |
| 2024-01-05 Option Award |
2024-01-09 5:00 pm |
N/A 2034-01-05 |
ATAI Life Sciences N.V. | ATAI | Angermayer Christian Director 10% Owner |
642,000 | $0 | 642,000 (Direct) |
View |
| 2023-05-23 Option Award |
2023-05-25 4:24 pm |
N/A 2033-05-23 |
ATAI Life Sciences N.V. | ATAI | JOHNSON SABRINA MARTUCCI Director |
64,000 | $0 | 64,000 (Direct) |
View |
| 2023-05-23 Option Award |
2023-05-25 4:19 pm |
N/A 2033-05-23 |
ATAI Life Sciences N.V. | ATAI | Auerbach Michael Director |
64,000 | $0 | 64,000 (Direct) |
View |
| 2023-05-23 Option Award |
2023-05-25 4:17 pm |
N/A 2033-05-23 |
ATAI Life Sciences N.V. | ATAI | Smiley Andrea Heslin Director |
64,000 | $0 | 64,000 (Direct) |
View |
| 2023-05-23 Option Award |
2023-05-25 4:16 pm |
N/A 2033-05-23 |
ATAI Life Sciences N.V. | ATAI | Camm Jason Director |
64,000 | $0 | 64,000 (Direct) |
View |
| 2023-05-23 Option Award |
2023-05-25 4:16 pm |
N/A 2033-05-23 |
ATAI Life Sciences N.V. | ATAI | Angermayer Christian Director 10% Owner |
64,000 | $0 | 64,000 (Direct) |
View |
| 2023-05-23 Option Award |
2023-05-25 4:15 pm |
N/A 2033-05-23 |
ATAI Life Sciences N.V. | ATAI | Kalali Amir H Director |
64,000 | $0 | 64,000 (Direct) |
View |
Ownership |
2023-05-19 5:36 pm |
N/A N/A |
ATAI Life Sciences N.V. | ATAI | Johnson Anne Nagengast Chief Accounting Officer |
0 | $0 | 1,414,188 (Direct) |
View |
| 2023-03-14 Option Award |
2023-03-16 8:27 pm |
N/A 2033-03-14 |
ATAI Life Sciences N.V. | ATAI | Rao Srinivas See Remarks |
950,000 | $0 | 950,000 (Direct) |
View |
| 2023-03-14 Option Award |
2023-03-16 8:24 pm |
N/A 2033-03-14 |
ATAI Life Sciences N.V. | ATAI | Brand Florian See Remarks |
2,300,000 | $0 | 2,300,000 (Direct) |
View |
| 2023-03-14 Option Award |
2023-03-16 8:23 pm |
N/A 2033-03-14 |
ATAI Life Sciences N.V. | ATAI | Bardin Stephen Chief Financial Officer |
950,000 | $0 | 950,000 (Direct) |
View |
| 2023-03-14 Option Award |
2023-03-16 8:22 pm |
N/A 2033-03-14 |
ATAI Life Sciences N.V. | ATAI | Gutierrez-Esteinou Rolando Chief Medical Officer |
700,000 | $0 | 700,000 (Direct) |
View |
| 2023-03-14 Option Award |
2023-03-16 8:20 pm |
N/A 2033-03-14 |
ATAI Life Sciences N.V. | ATAI | Kirpekar Sahil Chief Business Officer |
475,000 | $0 | 475,000 (Direct) |
View |
| 2022-12-01 Option Award |
2022-12-02 4:20 pm |
N/A 2032-12-01 |
ATAI Life Sciences N.V. | ATAI | Kirpekar Sahil Chief Business Officer |
750,000 | $0 | 750,000 (Direct) |
View |
Ownership |
2022-08-17 06:05 am |
N/A 2032-07-01 |
ATAI Life Sciences N.V. | ATAI | Bardin Stephen Chief Financial Officer |
0 | $0 | 1,000,000 (Direct) |
View |
| 2022-05-25 Option Award |
2022-05-27 5:55 pm |
N/A 2032-05-25 |
ATAI Life Sciences N.V. | ATAI | Smiley Andrea Heslin Director |
64,000 | $0 | 64,000 (Direct) |
View |
| 2022-05-25 Option Award |
2022-05-27 5:50 pm |
N/A 2032-05-25 |
ATAI Life Sciences N.V. | ATAI | Kalali Amir H Director |
64,000 | $0 | 64,000 (Direct) |
View |
| 2022-05-25 Option Award |
2022-05-27 5:49 pm |
N/A 2032-05-25 |
ATAI Life Sciences N.V. | ATAI | Auerbach Michael Director |
64,000 | $0 | 64,000 (Direct) |
View |
| 2022-05-25 Option Award |
2022-05-27 5:49 pm |
N/A 2032-05-25 |
ATAI Life Sciences N.V. | ATAI | Angermayer Christian Director 10% Owner |
64,000 | $0 | 64,000 (Direct) |
View |
| 2022-05-25 Option Award |
2022-05-27 5:46 pm |
N/A 2032-05-25 |
ATAI Life Sciences N.V. | ATAI | JOHNSON SABRINA MARTUCCI Director |
64,000 | $0 | 64,000 (Direct) |
View |